![Jean Franchi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean Franchi
Directeur Financier/CFO chez
DISC MEDICINE, INC.
Fortune : 88 226 $ au 31/05/2026
Profil
Jean M.
Franchi is currently Independent Director at Biodesix, Inc. since 2020, Director at VectorY BV, Chief Financial Officer at Disc Medicine Opco, Inc. since 2024, and Chief Financial Officer & Treasurer at Disc Medicine, Inc. since 2024.
Former roles include Director at International Institute of New England, Inc. from 2016 to 2019; Independent Director at Biophytis SA from 2017 to 2021; Independent Non-Executive Director at Visioneering Technologies, Inc. from 2017 to 2022; Director at Flamingo Therapeutics BV; Manager-Sales Analysis at Wyeth LLC; Controller & Senior VP-Corporate Finance at Genzyme Corp.
from 1995 to 2011; CFO, Treasurer & Principal Accounting Officer at Merrimack Pharmaceuticals, Inc. from 2017 to 2019; Senior Vice President-Business Unit Finance at Sanofi from 1995 to 2011; Senior Financial Analyst at bioMérieux, Inc.; Chief Financial Officer at Good Start Genetics, Inc. from 2012 to 2015; Chief Financial Officer, Secretary & Treasurer at Dimension Therapeutics, Inc. from 2015 to 2017; Chief Financial Officer, Secretary & Treasurer at Replimune Group, Inc. from 2019 to 2023; and Member-Supervisory Board at Dynacure SA. Education includes an undergraduate degree from Hofstra University conferred in 1992.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIODESIX, INC. 0,07% | 04/03/2026 | 5 406 ( 0,07% ) | 88 226 $ | 31/05/2026 |
DISC MEDICINE, INC. -.--% | 22/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Jean Franchi
| Sociétés | Poste | Début |
|---|---|---|
| BIODESIX, INC. | Directeur/Membre du Conseil | 01/04/2020 |
| DISC MEDICINE, INC. | Directeur Financier/CFO | 07/02/2024 |
VectorY BV
 VectorY BV BiotechnologyHealth Technology Develops vectorized antibody treatments for people with neurodegenerative diseases | Directeur/Membre du Conseil | - |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Directeur Financier/CFO | 01/02/2024 |
Anciens postes connus de Jean Franchi
| Sociétés | Poste | Fin |
|---|---|---|
Flamingo Therapeutics BV
 Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides RNA therapeutic drug development services | Directeur/Membre du Conseil | 01/03/2024 |
| REPLIMUNE GROUP, INC. | Directeur Financier/CFO | 02/06/2023 |
| VISG TECHUNSP GDR | Directeur/Membre du Conseil | 19/12/2022 |
| BIOPHYTIS S.A. | Directeur/Membre du Conseil | 07/07/2021 |
| MERRIMACK PHARMACEUTICALS | Directeur Financier/CFO | 28/06/2019 |
Formation de Jean Franchi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Biodesix, Inc.
 Biodesix, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic research and clinical trial testing services & engages in discovery, development and commercialization of therapeutics | Health Services |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Hofstra University
 Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute of New England, Inc.
 International Institute of New England, Inc. Services to the Health IndustryHealth Services Operates charitable organization for refugees and immigrants | Health Services |
bioMérieux, Inc.
 bioMérieux, Inc. Medical SpecialtiesHealth Technology Develops in-vitro diagnostics solutions | Health Technology |
Biophytis SA
 Biophytis SA Pharmaceuticals: OtherHealth Technology Develops and markets dietary supplements and ingredients for functional food based on tropical plants | Health Technology |
Visioneering Technologies, Inc.
 Visioneering Technologies, Inc. Medical SpecialtiesHealth Technology Designs and markets contact lenses | Health Technology |
Good Start Genetics, Inc.
 Good Start Genetics, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostics services | Health Services |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for rare diseases | Health Technology |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Develops novel therapies to transform the lives of patients | Health Services |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Commercial Services |
Flamingo Therapeutics BV
Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides RNA therapeutic drug development services | Commercial Services |
VectorY BV
VectorY BV BiotechnologyHealth Technology Develops vectorized antibody treatments for people with neurodegenerative diseases | Health Technology |
Disc Medicine, Inc.
 Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Choisissez Zonebourse 
